North America Clinical Trials Supplies Markets Report 2021-2027: COVID-19 Impact and Analysis by Product & Service, Stage, Drug Type, and Applications – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “North America Clinical Trials Supplies Market Forecast to 2027 – COVID-19 Impact and Regional Analysis by Product & Service, Stage, Drug Type, and Application” report has been added to ResearchAndMarkets.com’s offering.

The North America clinical trial supplies market is expected to reach US$ 1,364.10 million by 2027 from US$ 758.95 million in 2019; it is estimated to grow at a CAGR of 7.7% from 2020 to 2027.

The growth of the market is attributed to some key driving factors such as increase in R&D expenditures by the pharmaceutical & biopharmaceutical companies, rise in number of clinical trials, and higher costs of drug development in developed nations.

However, challenges for clinical trials due to the negative impact of COVID-19 pandemic are expected to restrain the growth of the market during the forecast years.

The clinical trial is an investigational study that defines whether a medical approach, therapy, or device is effective, safe, and useful for human applications. These studies help to find which therapeutic approach is best for certain diseases. Clinical trial supplies management is necessary for evading overproduction, oversupply, and inventory expiration.

With the increasing costs of drug discovery, clinical trial supplies are obtaining more importance. Research and development (R&D) is a significant and essential part of the business of pharmaceuticals and biopharmaceuticals companies. R&D spending by biopharmaceuticals companies has increased over the years.

Several manufacturers are investing in clinical supplies in the pharmaceutical industry. Therefore, the pharmaceutical and biotech companies are dependent on the supplies for the services to the clinical trials, which is expected to drive the market. Also, advanced health care infrastructure and presence of multinational pharmaceutical and biotechnology companies that carry out clinical trials in North America will bolster the market growth.

Key Topics Covered:

1. Introduction

1.1 Scope of the Study

1.2 Research Report Guidance

1.3 Market Segmentation

2. Clinical Trial Supplies Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Clinical Trial Supplies Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Expert Opinion

5. Clinical Trial Supplies Market- Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Pharmaceutical and Biopharmaceutical R&D Expenditures

5.1.2 Higher Cost of Drug Development Process in Developed Countries

5.2 Market Restraints

5.2.1 Rising Cost of Drug Development and Clinical Trials

5.2.2 Challenges for Clinical Trials Due to Negative Impact of Corona Virus

5.3 Future Trends

5.3.1 Growing Biosimilars and Biologics Market

5.4 Impact analysis

6. Clinical Trial Supplies Market – North America Analysis

6.1 North America Clinical Trial Supplies Market Revenue Forecast and Analysis

7. Clinical Trial Supplies Market Analysis – By Product and Service

7.1 Overview

7.2 Clinical Trial Supplies Market Revenue Share, by Product and Service (2019 and 2027)

7.3 Logistics & Distribution

7.3.1 Overview

7.3.2 Logistics & Distribution: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

7.4 Manufacturing

7.5 Packaging & Labelling

8. Clinical Trial Supplies Market – By Stage

8.1 Overview

8.2 Clinical Trial Supplies Market, by Stage, 2019 and 2027 (%)

8.3 Phase III

8.3.1 Overview

8.3.2 Phase III: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Phase II

8.5 Bioequivalence Studies

8.6 Phase I

9. Clinical Trial Supplies Market – By Drug Type

9.1 Overview

9.2 Clinical Trial Supplies Market, by Drug Type 2019 and 2027 (%)

9.3 Small-molecule Drugs

9.3.1 Overview

9.3.2 Small-molecule Drugs: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

9.4 Biologic Drugs

10. Clinical Trial Supplies Market – By Application

10.1 Overview

10.2 Clinical Trial Supplies Market, by Application 2019 and 2027 (%)

10.3 Oncology

10.3.1 Overview

10.3.2 Oncology: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

10.4 Cardiovascular Diseases

10.5 Neurological Disorders

10.6 Respiratory Disorders

11. Clinical Trial Supplies Market – North America Analysis

11.1 North America: Clinical Trial Supplies Market

11.1.1 Overview

11.1.2 North America: Clinical Trial Supplies Market, by Country, 2019 & 2027 (%)

12. Impact of COVID-19 Pandemic on North America Clinical Trial Supplies Market

12.1 North America: Impact Assessment of COVID-19 Pandemic

13. Clinical Trials Supplies Market – Industry Landscape

13.1 Overview

13.2 Organic Developments

13.3 Inorganic Developments

14. Clinical Trial Supplies Market – Key Company Profiles

• Thermo Fisher Scientific
• UDG Healthcare plc
• Catalent Inc.
• pci Pharma Services
• Almac Group
• ParexelL Int’l
• Biocair
• Owens & Minor Inc
• Rubicon Research Pvt. Ltd
• Clinical Supplies Management Holdings, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/bql8us

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900